array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2495) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(67) "Gene Therapy Market Forecasted to Surpass USD 38.33 Billion by 2030" ["snippet_en"]=> string(280) "The Gene Therapy Market exhibited substantial growth, reaching USD 9.42 Billion in 2023 and is anticipated to escalate to USD 38.33 Billion by 2030. This growth trajectory signifies a robust compound annual growth rate (CAGR) of 22.2% during the forecast period from 2023 to 2030." ["url"]=> string(126) "https://www.whatech.com/og/markets-research/medical/811369-gene-therapy-market-forecasted-to-surpass-usd-38-33-billion-by-2030" ["image_url"]=> NULL ["source"]=> string(11) "whatech.com" ["publication_date"]=> string(10) "2024-04-01" ["categories"]=> array(2) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(15) "Market Movement" } } [1]=> array(7) { ["title_en"]=> string(116) "Non-Hematological Cancers Market to See Incredible Growth 2024-2031 |Novartis, Pfizer, Bristol-Myers Squibb - Amoré" ["snippet_en"]=> string(116) "Non-Hematological Cancers Market to See Incredible Growth 2024-2031 |Novartis, Pfizer, Bristol-Myers Squibb - Amoré" ["url"]=> string(135) "https://amore.ng/worldwide/14/non-hematological-cancers-market-to-see-incredible-growth-2024-2031-novartis-pfizer-bristol-myers-squibb/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c717e747-4d2e-4473-9ce2-31a6ecf71096" ["source"]=> string(8) "amore.ng" ["publication_date"]=> string(10) "2024-03-13" ["categories"]=> array(2) { [0]=> string(11) "Competition" [1]=> string(15) "Market Movement" } } [2]=> array(7) { ["title_en"]=> string(94) "Sex Toys Market to Expand Robustly in 2024| Ansell, BMS Factory, LELO, LUVU BRANDS - Newstrail" ["snippet_en"]=> string(155) "Advance Market Analytics published a new research publication on "Sex Toys Market Insights, to 2030" with 232 pages and enriched with self-explained Tables" ["url"]=> string(105) "https://www.newstrail.com/sex-toys-market-to-expand-robustly-in-2024-ansell-bms-factory-lelo-luvu-brands/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2e9956f5-5f48-4a99-b9fc-73a8f01c6ae6" ["source"]=> string(13) "newstrail.com" ["publication_date"]=> string(10) "2024-03-08" ["categories"]=> array(3) { [0]=> string(11) "Competition" [1]=> string(15) "Market Movement" [2]=> string(18) "Expansion & Growth" } } [3]=> array(7) { ["title_en"]=> string(43) "BMS: Related Party Transactions | Vietstock" ["snippet_en"]=> string(129) "Mr. Trinh Van Quyet manipulates the stock market? Mr. Trinh Van Quyet manipulates the stock market? Financial information portal-" ["url"]=> string(76) "https://vietstock.vn/2024/03/bms-giao-dich-voi-ben-lien-quan-830-1161087.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/543b45da-0f70-46b7-8ec5-99e4f47546a7" ["source"]=> string(12) "vietstock.vn" ["publication_date"]=> string(10) "2024-03-04" ["categories"]=> array(3) { [0]=> string(26) "Related Party Transactions" [1]=> string(12) "Stock Market" [2]=> string(15) "Market Movement" } } [4]=> array(7) { ["title_en"]=> string(96) "Albumin-bound Paclitaxel Market An Professional Research Report 2024-2030 | Survey by QYResearch" ["snippet_en"]=> string(96) "Albumin-bound Paclitaxel Market An Professional Research Report 2024-2030 | Survey by QYResearch" ["url"]=> string(153) "https://industrytoday.co.uk/market-research-industry-today/albumin-bound-paclitaxel-market-an-professional-research-report-2024-2030-survey-by-qyresearch" ["image_url"]=> NULL ["source"]=> string(19) "industrytoday.co.uk" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(4) { [0]=> string(19) "Economic Conditions" [1]=> string(5) "R & D" [2]=> string(17) "Academic Research" [3]=> string(15) "Market Movement" } } [5]=> array(7) { ["title_en"]=> string(99) "GLP-1 for Diabetes Market Opportunities, Sales, Revenue, Gross Margin & Trends Analysis Report 2024" ["snippet_en"]=> string(99) "GLP-1 for Diabetes Market Opportunities, Sales, Revenue, Gross Margin & Trends Analysis Report 2024" ["url"]=> string(153) "https://industrytoday.co.uk/market-research-industry-today/glp-1-for-diabetes-market-opportunities-sales-revenue-gross-margin-trends-analysis-report-2024" ["image_url"]=> NULL ["source"]=> string(19) "industrytoday.co.uk" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(2) { [0]=> string(19) "New Revenue Streams" [1]=> string(15) "Market Movement" } } [6]=> array(7) { ["title_en"]=> string(60) "The 3 Best Stocks Beginning Investors Can Buy: February 2024" ["snippet_en"]=> string(129) "Starting your investment journey? Navigate the market with confidence! Discover 3 stocks for beginning investors in this article." ["url"]=> string(94) "https://investorplace.com/2024/02/the-3-best-stocks-beginning-investors-can-buy-february-2024/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/83918bdc-ad3e-437b-8102-171f3e499100" ["source"]=> string(17) "investorplace.com" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(11) { [0]=> string(25) "Business Model Resilience" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(19) "Investment Requests" [3]=> string(31) "Financial Update/Profit Warning" [4]=> string(15) "Market Movement" [5]=> string(24) "Stock Research & Ratings" [6]=> string(18) "Financial Distress" [7]=> string(9) "Investors" [8]=> string(12) "Stock Market" [9]=> string(18) "Expansion & Growth" [10]=> string(18) "General Investment" } } [7]=> array(7) { ["title_en"]=> string(80) "Bristol-Myers Squibb (NYSE:BMY) - Stock Price, News & Analysis - Simply Wall St" ["snippet_en"]=> string(163) "Research Bristol-Myers Squibb's (NYSE:BMY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more." ["url"]=> string(85) "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bmy/bristol-myers-squibb" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4de830b8-96f1-41ad-9b3a-d3f1302099c4" ["source"]=> string(13) "simplywall.st" ["publication_date"]=> string(10) "2024-02-18" ["categories"]=> array(5) { [0]=> string(21) "Shareholders Feedback" [1]=> string(24) "Stock Research & Ratings" [2]=> string(12) "Stock Market" [3]=> string(11) "Acquisition" [4]=> string(15) "Market Movement" } } [8]=> array(7) { ["title_en"]=> string(35) "10 Blue-Chip Stocks At 52-Week Lows" ["snippet_en"]=> string(284) "In this piece, we will take a look at the ten blue chip stocks at 52 week lows. If you want to skip the latest stock market news, then you can take a look at the 5 Blue-Chip Stocks At 52-Week Lows. The end of January has provided the media and investors with crucial information [...]" ["url"]=> string(71) "https://uk.finance.yahoo.com/news/10-blue-chip-stocks-52-100410984.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/45ada533-a08b-4b07-8d8d-956e08518f0f" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-02-02" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(15) "Market Movement" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(254) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(163) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(151) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(89) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(76) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(74) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(63) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(56) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(54) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [15]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [16]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(39) } [19]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [20]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(33) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(32) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company

Bristol-Myers Squibb Company

Location

New York

Founded

1887-02-28

Website

https://www.bms.com

Articles

2495 Articles

Category

Pharmaceutical Preparations

Description

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Articles

Gene Therapy Market Forecasted to Surpass USD 38.33 Billion by 2030

2024-04-01 (whatech.com)

Gene Therapy Market Forecasted to Surpass USD 38.33 Billion by 2030

The Gene Therapy Market exhibited substantial growth, reaching USD 9.42 Billion in 2023 and is anticipated to escalate to USD 38.33 Billion by 2030. This growth trajectory signifies a robust compound annual growth rate (CAGR) of 22.2% during the forecast period from 2023 to 2030.

Read more
Non-Hematological Cancers Market to See Incredible Growth 2024-2031 |Novartis, Pfizer, Bristol-Myers Squibb - Amoré

2024-03-13 (amore.ng)

Non-Hematological Cancers Market to See Incredible Growth 2024-2031 |Novartis, Pfizer, Bristol-Myers Squibb - Amoré

Non-Hematological Cancers Market to See Incredible Growth 2024-2031 |Novartis, Pfizer, Bristol-Myers Squibb - Amoré

Read more
Sex Toys Market to Expand Robustly in 2024| Ansell, BMS Factory, LELO, LUVU BRANDS - Newstrail

2024-03-08 (newstrail.com)

Sex Toys Market to Expand Robustly in 2024| Ansell, BMS Factory, LELO, LUVU BRANDS - Newstrail

Advance Market Analytics published a new research publication on "Sex Toys Market Insights, to 2030" with 232 pages and enriched with self-explained Tables

Read more
BMS: Related Party Transactions | Vietstock

2024-03-04 (vietstock.vn)

BMS: Related Party Transactions | Vietstock

Mr. Trinh Van Quyet manipulates the stock market? Mr. Trinh Van Quyet manipulates the stock market? Financial information portal-

Read more
Albumin-bound Paclitaxel Market An Professional Research Report 2024-2030 | Survey by QYResearch

2024-02-21 (industrytoday.co.uk)

Albumin-bound Paclitaxel Market An Professional Research Report 2024-2030 | Survey by QYResearch

Albumin-bound Paclitaxel Market An Professional Research Report 2024-2030 | Survey by QYResearch

Read more
GLP-1 for Diabetes Market Opportunities, Sales, Revenue, Gross Margin & Trends Analysis Report 2024

2024-02-21 (industrytoday.co.uk)

GLP-1 for Diabetes Market Opportunities, Sales, Revenue, Gross Margin & Trends Analysis Report 2024

GLP-1 for Diabetes Market Opportunities, Sales, Revenue, Gross Margin & Trends Analysis Report 2024

Read more
The 3 Best Stocks Beginning Investors Can Buy: February 2024

2024-02-21 (investorplace.com)

The 3 Best Stocks Beginning Investors Can Buy: February 2024

Starting your investment journey? Navigate the market with confidence! Discover 3 stocks for beginning investors in this article.

Read more
Bristol-Myers Squibb (NYSE:BMY) - Stock Price, News & Analysis  - Simply Wall St

2024-02-18 (simplywall.st)

Bristol-Myers Squibb (NYSE:BMY) - Stock Price, News & Analysis - Simply Wall St

Research Bristol-Myers Squibb's (NYSE:BMY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.

Read more
10 Blue-Chip Stocks At 52-Week Lows

2024-02-02 (yahoo.com)

10 Blue-Chip Stocks At 52-Week Lows

In this piece, we will take a look at the ten blue chip stocks at 52 week lows. If you want to skip the latest stock market news, then you can take a look at the 5 Blue-Chip Stocks At 52-Week Lows. The end of January has provided the media and investors with crucial information [...]

Read more

Newsletter subscription